E Kerukadho - Concepedia

Author

E Kerukadho

Also Known As

E Kerukadho, Emmanuel Kerukadho

Publications

189

Citations

H-Index

Concepts

All Affiliations

E Kerukadho is an author at Infectious Diseases Institute specializing in malaria, immunodeficiencies, and aids pathogenesis.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	29
2	Public Health	1	1	29
3	Epidemiology	1	1	29
4	Global Health	1	1	29
5	Immunology	1	1	29

E Kerukadho

Publications

189

Citations

H-Index

Page 1

	Year	Citations
Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial Nicholas I. Paton, Cissy Kityo, Immaculate Nankya, The Lancet HIV	2017	79
Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial James Hakim, Cissy Kityo, Anne Hoppé, The Lancet Infectious Diseases	2017	41
Virological failure reduced with HIV-serostatus disclosure, extra baseline weight and rising CD4 cells among HIV-positive adults in Northwestern Uganda Jonathan Izudi, Sunday Alioni, E Kerukadho, BMC Infectious Diseases	2016	29
Hookworm infection is associated with decreased CD4+ T cell counts in HIV-infected adult Ugandans Bożena M Morawski, Yunus Miya, E Kerukadho, PLoS neglected tropical diseases Parasitic DiseaseImmunodeficienciesMalariaImmunologyHookworm Infection	2017	29
Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized Trial Cissy Kityo, David Dunn, Anne Hoppé, Clinical Infectious Diseases	2018	11

Page 1